A comprehensive review of literature was conducted to identify the barriers and facilitators, from the parents'/guardians' and primary care providers' (PCPs) perspective, that are associated with the uptake of Human Papillomavirus (HPV) vaccine among adolescent females. Findings from 14 peer-reviewed articles indicate that 37% of adolescent females, 9 to 17 years of age, initiated the HPV vaccine, compared to the national average of 13- to 15-years-olds, which is 50%. The overall uptake and completion rates of the vaccine were low across all racial and ethnic groups. Barriers included parents'/guardians' knowledge, perceptions, and attitudes toward the HPV disease and the vaccine, along with the convenience in receiving the vaccine. Six studies reported that HPV vaccine initiation was highly likely if the parents/guardians had received a doctor’s recommendation. Learning what interventions school nurses currently utilize could positively affect the HPV vaccine uptake and completion rates by other nursing disciplines realizing this ongoing effort.
AndreF. E.BooyR.BockH. L.ClemensJ.DattaS. K.JohnT. J.… SchmittH. J. (2008).
Vaccination greatly reduces disease, disability, death and inequity worldwideBulletin of the World Health Organization,
8681–160.
3.
BlockS. L.NolanT.SattlerC.BarrE.GiacolettiK. E.MarchantC. D.… ReisingerK. S. (2006).
Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult womenPediatrics,
1182135–2145.
4.
BrabinL.RobertsS. A.StretchR.BaxterD.EltonP.KitchenerH.McCannR. (2009)
A survey of adolescent experiences of human papillomavirus vaccination in the Manchester studyBritish Journal of Cancer,
1011502–1504.
5.
BuchbinderM. H.DetzerM. J.WelschR. L.ChristianoA. S.PatashnickJ. L.RichM.
(2005)
Assessing adolescents with insulin-dependent diabetes mellitus: A multiple perspective pilot study using visual illness narratives and interviewsThe Journal of Adolescent Health: Official Publication of the Society for Adolescent Medicine,
3671.e79–71.e13.
6.
BurchMInderbitzinKRobargeDZacharskiS (2010). National association of school nurses: Immunizations position statementRetrieved fromhttp://www.nasn.org/Default.aspx?tabid=225
Centers for Disease Control and Prevention.
(2007)
Quadrivalent human papillomavirus vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)MMWR: Morbidity & Mortality Weekly Report,
561–23.
9.
Centers for Disease Control and Prevention. (2009).Sexually transmitted diseases: Genital HPV infection-fact sheet. Retrieved from http://www.cdc.gov/std/hpv/stdfact-hpv.htm
10.
Centers for Disease Control and Prevention
(2010)
National, state, and local area vaccination coverage among adolescents aged 13-17 years–United States, 2009MMWR: Morbidity & Mortality Weekly Report,
591018–1023.
ChaoC.SlezakJ. M.ColemanK. J.JacobsenS. J. (1998)
Papanicolaou screening behavior in mothers and human papillomavirus vaccine uptake in adolescent girlsAmerican Journal of Public Health,
991137–1142.
13.
ChaoC.VelicerC.SlezakJ. M.JacobsenS. J.
(1998)
Correlates for completion of 3-dose regimen of HPV vaccine in female members of a managed care organizationMayo Clinic Proceedings,
84864–870.
14.
ChaoC.VelicerC.SlezakJ. M.JacobsenS. J. (2009)
Correlates for human papillomavirus vaccination of adolescent girls and young women in a managed care organizationAmerican Journal of Epidemiology,
171357–367.
15.
ColgroveJ.AbiolaS.MelloM. M. (2010)
HPV vaccination mandates—Lawmaking amid political and scientific controversyNew England Journal of Medicine,
363785–791.
16.
Committee on Infectious Diseases.
(2007)
Prevention of human papillomavirus infection: Provisional recommendations for immunization of girls and women with quadrivalent human papillomavirus vaccinePediatrics,
120666–668doi: 10.1542/ peds.2007-1735
17.
Cooper RobbinsS. C.BernardD.McCafferyK.BrothertonJ.GarlandS.SkinnerS. R.
(2010)
“Is cancer contagious?” Australian adolescent girls and their parents: Making the most of limited information about HPV and HPV vaccinationVaccine,
283398–3408.
18.
DaleyM. F.CraneL. A.MarkowitzL. E.BlackS. R.BeatyB. L.BarrowJ.… KempeA.
(2010)
Human papillomavirus vaccination practices: A survey of US physicians 18 months after licensurePediatrics,
126425–433.
19.
DempseyA. F.AbrahamL. M.DaltonV.RuffinM.
(2009)
Understanding the reasons why mothers do or do not have their adolescent daughters vaccinated against human papillomavirusAnnals of Epidemiology,
19531–538.
20.
DempseyA. F.ZimetG. D.DavisR. L.KoutskyL.
(2006)
Factors that are associated with parental acceptance of human papillomavirus vaccines: A randomized intervention study of written information about HPVPediatrics,
1171486–1493.
21.
EhrhardtJ.
(2007)
What school nurses need to know about cervical cancer, HPV, and the new vaccineJournal of School Nursing,
23310–314.
22.
FreedG. L.ClarkS. J.ButchartA. T.SingerD. C.DavisM. M.
(2010)
Parental Vaccine Safety Concerns in 2009Pediatrics,
125654–659doi: 10.1542/peds.2009-1962
23.
GerendM. A.WeibleyE.BlandH.
(2009)
Parental response to human papillomavirus vaccine availability: Uptake and intentionsJournal of Adolescent Health,
45528–531.
24.
GottliebS. L.BrewerN. T.SternbergM. R.SmithJ. S.ZiarnowskiK.LiddonN.MarkowitzL. E.
(2009)
Human papillomavirus vaccine initiation in an area with elevated rates of cervical cancerJournal of Adolescent Health,
45430–437.
25.
HarperD. M.FrancoE. L.WheelerC. M.MoscickiA.-B.RomanowskiB.Roteli-MartinsC. M.… DubinG.
(2006)
Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: Follow-up from a randomised control trialLancet,
3671247–1255doi: 10.1016/s0140-6736(06)68439-0
26.
HiltonS.HuntK.LanganM.BedfordH.PetticrewM.
(2010)
Newsprint media representations of the introduction of the HPV vaccination programme for cervical cancer prevention in the UK ( 2005–2008)Social Science & Medicine,
70942–950.
27.
HughesJ.CatesJ. R.LiddonN.SmithJ. S.GottliebS. L.BrewerN. T.
(2009)
Disparities in how parents are learning about the human papillomavirus vaccineCancer Epidemiology, Biomarkers & Prevention,
18363–372.
28.
LaceyC. J. N.LowndesC. M.ShahK. V.
(2006)
Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 diseaseVaccine,
24S35–S41doi: 10.1016/j.vaccine.2006.06.015
29.
MoscickiA.-B. (2005)
Impact of HPV infection in adolescent populationsJournal of Adolescent Health,
37S3–S9doi: 10. 1016/j.jadohealth.2005.09.011
30.
MoscickiA.-B.SchiffmanM.KjaerS.VillaL. L.
(2006)
Chapter 5: Updating the natural history of HPV and anogenital cancerVaccine,
24S42–S51doi: 10.1016/j.vaccine.2006.06.018
31.
MuñozN.CastellsaguéXDe GonzálezA. B.GissmannL.
(2006)
Chapter 1: HPV in the etiology of human cancerVaccine,
24S1–S10doi: 10.1016/j.vaccine.2006.05.115
OlshenE.WoodsE. R.AustinS. B.LuskinM.BauchnerH.
(2005)
Parental acceptance of the human papillomavirus vaccineJournal of Adolescent Health,
37248–251.
35.
OonS.-F.WinterD. C.
(2010)
Perianal condylomas, anal squamous intraepithelial neoplasms and screening: A review of the literatureJournal of Medical Screening,
1744–49doi: 10.1258/jms.2009.009058
36.
PerkinsR. B.Pierre-JosephN.MarquezC.IlokaS.ClarkJ. A.
(2010)
Why do low-income minority parents choose human papillomavirus vaccination for their daughters?Journal of Pediatrics,
157617–622.
37.
ReiterP. L.BrewerN. T.GottliebS. L.McReeA.-L.SmithJ. S.
(2009)
Parents' health beliefs and HPV vaccination of their adolescent daughtersSocial Science & Medicine,
69475–480.
38.
RosenthalS. L.RuppR.ZimetG. D.MezaH. M.LozaM. L.ShortM. B.SuccopP. A.
(2008)
Uptake of HPV vaccine: Demographics, sexual history and values, parenting style, and vaccine attitudesJournal of Adolescent Health,
43239–245.
39.
SchiffmanM.KjaerS.
(2003)
Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasiaJournal of the National Cancer Institute Monographs,
3114–19.
40.
SchnatzP. F.HumphreyK.O’SullivanD. M.
(2010)
Assessment of the perceptions and administration of the human papillomavirus vaccineJournal of Lower Genital Tract Disease,
14103–107.
41.
SibbittW. L.BrandtJ. R.JohnsonC. R.WongC. S.BankhurstA. D.
(2007)
Needle phobia and stress-reducing medical devices in pediatric and adult chemotherapy patientsJournal of Pediatric Oncology Nursing,
2420–208doi: 10.1177/ 1043454206296023
42.
SteinbrookR.
(2006)
The potential of human papillomavirus vaccinesThe New England Journal of Medicine,
3541109–1112.
43.
StretchR.RobertsS. A.McCannR.BaxterD.ChambersG.KitchenerH.BrabinL.
(2008)
Parental attitudes and information needs in an adolescent HPV vaccination programmeBritish Journal of Cancer,
991908–1911.
44.
TrottierH.FrancoE. L.
(2006)
The epidemiology of genital human papillomavirus infectionVaccine,
24S1/4– S1/15doi: 10.1016/j.vaccine.2005.09.054
WeinstockH.BermanS.CatesW.Jr.
(2004)
Sexually transmitted diseases among American youth: Incidence and prevalence estimates, 2000Perspectives on Sexual & Reproductive Health,
366–10.
48.
YeganehN.CurtisD.KuoA.
(2010)
Factors influencing HPV vaccination status in a Latino population; and parental attitudes towards vaccine mandatesVaccine,
284186–4191.
